I wish to share my experience regarding misuse of corticosteroids in
pediatric practice since 1993, when I returned from Gulf and settled in
city of Ujjain (MP). It is not surprising to see irrational prescriptions
of corticosteroids from qualified pediatricians. Corticosteroids are
frequently misused in respiratory infections, acute bronchiolitis and
prolonged fever. Prescriptions are also written advising injectable
steroids to be mixed with injectable antibiotics on outpatient basis (eg.
Inj. amoxicillin with Inj. dexamethosone).
Betamethosone in drop form is available in our country
since long time. I personally feel that it is one of the most misused
corticosteroid given orally to young infants. I evaluated the consumption
of betamethesone drops in Ujjain and Shajapur district in last 3 years.
The sale of one of the leading brands "Betnesol drops" manufactured by
Glaxo company in last 3 years was 24,200 (2006), 22138 (2007) and 30140
(2008) bottles, respectively. These figures were shocking. The exact sale
of one more brand, Stemin drops manufactured by Ind-Swift Co. was not
available, but rough estimation of sale provided to me was around 8000
bottles per year. Apart from these two if we also include the sale of
generic formulation (approximately 6000 bottles per year) then the total
number of bottles of betamethasone drops sold goes beyond 40000 per year.
If this is the situation in small district of Ujjain and Shajapur, then
one can imagine the situation at state or national level; the figure may
be in millions. I was also informed that for many years company has
stopped promoting this product to doctors, yet the sale remains
unaffected.
There is no genuine indication to use betamethasone
drops in young infants and I have not used this drug in my 25 years of
practice. I request IAP to take action to protect our young infants.